Schwarz A, Futerman AH (1997) Distinct roles for ceramide and glucosylceramide at dierent
stages of neuronal growth. J Neurosci 17 : 2929 ̈2938.
Schwarz A, Futerman AH (1998) Inhibition of sphingolipid synthesis, but not degradation,
alters the rate of dendrite growth in cultured hippocampal neurons. Brain Res Dev Brain
Res 108 : 125 ̈130.
Schwarz A, Rapaport E, Hirschberg K, Futerman AH (1995) A regulatory role for sphingolipids in neuronal growth : inhibition of sphingolipid synthesis and degradation have
opposite eects on axonal branching. J Biol Chem 270 : 10990 ̈10998.
Schwarzmann G, Hofmann P, Pu tz T, Albrecht B (1995) Demonstration of direct glycosylation of nondegradable glucosylceramide analogs in cultured cells. J Biol Chem 270 : 21271 ̈
21276.
Sidransky E, Sherer DM, Ginns EI (1992) Gaucher disease in the neonate : a distinct gaucher
phenotype is analogous to a mouse model created by targeted disruption of the glucocerebrosidase gene. Pediatr Res 32 : 494 ̈498.
Sofer A, Schwarzmann G, Futermann AH (1996) The internalization of a short acyl chain
analogue of ganglioside GM(1) in polarized neurons. J Cell Sci 109 : 2111 ̈2119.
Suzuki K (1998) Twenty —ve years of the psychosine hypothesisˇ : a personal perspective of its
history and present status. Neurochem Res 23 : 251 ̈259.
Tybulewicz VLJ, Tremblay ML, LaMrca ME, et al (1992) Animal model of Gaucherˇs disease
from targeted disruption of the mouse glucocerebrosidase gene. Nature 357 : 407 ̈410.
Vahter M, Marafante E (1987) Eects of low dietary intake of methionine, choline or proteins
on the biotransformation of arsenite in the rabbit. T oxicol L ett 37 : 41 ̈46.
Willemsen R, Tybulewicz V, Sidransky E, et al (1995) A biochemical and ultrastructural
evaluation of the type 2 Gaucher mouse. Mol Chem Neuropathol 24 : 179 ̈192.
Zirzow CC, Sanchez OA, Murray GJ, Brady RO, Old—eld EH (1999) Delivery, distribution,
and neuronal uptake of exogeneous mannose-terminal glucocerobrosidase in the intact
brain. Neurochem Res 24 : 310 ̈315.
